Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Plainsboro, New Jersey 08536


Purpose:

This study is conducted in the United States of America (USA). The aim of this study is to investigate the at-home-administration of bypassing agents for treatment of bleeding episodes in patients with congenital haemophilia with inhibitors to factors VIII and IX. We are further investigating how bleeding episodes affect the quality of life of the patient and their family or caregivers.


Criteria:

Inclusion Criteria: - Male subjects with congenital haemophilia A or B and inhibitors with spontaneous bleeds which require on-demand treatment - Subjects prescribed NovoSeven® as the first line or recommended bypass agent - History of on average at least 4 bleeds of any type over a 3 month period - Subject or caregiver able and willing to complete daily journal for 3 months - Informed consent obtained from all subjects or legal representative


NCT ID:

NCT00710619


Primary Contact:

Study Director
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S


Backup Contact:

N/A


Location Contact:

Plainsboro, New Jersey 08536
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.